HALO
Halozyme Therapeutics Inc
NASDAQ: HALO · HEALTHCARE · BIOTECHNOLOGY
$63.06
-1.25% today
Updated 2026-04-29
Market cap
$7.47B
P/E ratio
24.63
P/S ratio
5.35x
EPS (TTM)
$2.56
Dividend yield
—
52W range
$48 – $82
Volume
1.6M
Halozyme Therapeutics Inc (HALO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $981746.00 | $3.80M | $8.76M | $13.67M | $13.62M | $56.09M | $42.33M | $54.80M | $75.33M | $135.06M | $146.69M | $316.61M | $151.86M | $195.99M | $267.59M | $443.31M | $660.12M | $829.25M | $1.02B | $1.40B |
| Revenue growth (YoY) | — | +287.0% | +130.7% | +56.0% | -0.3% | +311.7% | -24.5% | +29.5% | +37.5% | +79.3% | +8.6% | +115.8% | -52.0% | +29.1% | +36.5% | +65.7% | +48.9% | +25.6% | +22.4% | +37.6% |
| Cost of revenue | $436990.00 | $240429.00 | $332324.00 | $311891.00 | $985283.00 | $257834.00 | $1.09M | $6.25M | $22.73M | $29.25M | $33.21M | $31.15M | $10.14M | $45.55M | $43.37M | $81.41M | $139.30M | $192.36M | $159.42M | $305.44M |
| Gross profit | $544756.00 | $3.56M | $8.43M | $13.36M | $12.64M | $55.83M | $41.23M | $48.55M | $52.60M | $105.81M | $113.48M | $285.46M | $141.73M | $150.45M | $224.23M | $361.90M | $520.81M | $636.89M | $855.91M | $1.09B |
| Gross margin | 55.5% | 93.7% | 96.2% | 97.7% | 92.8% | 99.5% | 97.4% | 88.6% | 69.8% | 78.3% | 77.4% | 90.2% | 93.3% | 76.8% | 83.8% | 81.6% | 78.9% | 76.8% | 84.3% | 78.1% |
| R&D | $9.21M | $20.55M | $44.23M | $56.61M | $51.77M | $57.56M | $70.04M | $96.64M | $79.70M | $93.24M | $150.84M | $150.64M | $150.25M | $140.80M | $34.24M | $35.67M | $66.61M | $76.36M | $79.05M | $81.49M |
| SG&A | $6.91M | $11.16M | $14.63M | $15.20M | $15.12M | $18.10M | $24.81M | $32.35M | $35.94M | $40.03M | $45.85M | $53.82M | $60.80M | $77.25M | $45.74M | $50.32M | $143.53M | $149.18M | $154.34M | $207.09M |
| Operating income | $-15.58M | $-28.15M | $-50.43M | $-58.46M | $-54.26M | $-19.84M | $-53.63M | $-80.43M | $-63.04M | $-27.45M | $-83.21M | $81.00M | $-69.33M | $-67.61M | $144.25M | $275.90M | $267.53M | $337.57M | $551.48M | $816.29M |
| Operating margin | -1587.3% | -740.9% | -575.5% | -427.6% | -398.2% | -35.4% | -126.7% | -146.8% | -83.7% | -20.3% | -56.7% | 25.6% | -45.7% | -34.5% | 53.9% | 62.2% | 40.5% | 40.7% | 54.3% | 58.4% |
| EBITDA | $-14.51M | $-28.15M | $-49.39M | $-56.92M | $-52.75M | $-18.67M | $-52.55M | $-79.21M | $-61.27M | $-25.77M | $-80.80M | $83.16M | $-66.94M | $-63.54M | $147.54M | $278.90M | $315.51M | $451.95M | $656.54M | $904.34M |
| EBITDA margin | -1477.8% | -740.9% | -563.5% | -416.3% | -387.2% | -33.3% | -124.1% | -144.5% | -81.3% | -19.1% | -55.1% | 26.3% | -44.1% | -32.4% | 55.1% | 62.9% | 47.8% | 54.5% | 64.7% | 64.8% |
| EBIT | $-14.75M | $-28.73M | $-50.43M | $-58.36M | $-54.26M | $-19.77M | $-53.63M | $-80.43M | $-63.04M | $-27.45M | $-83.21M | $81.00M | $-69.33M | $-67.61M | $144.25M | $275.90M | $265.87M | $367.09M | $575.23M | $816.29M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.27M | $5.58M | $5.20M | $19.98M | $21.98M | $18.04M | $11.63M | $20.38M | $7.53M | $16.95M | $18.76M | $18.09M | $18.13M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-14.75M | $-23.90M | $-48.65M | $-58.36M | $-53.24M | $-19.77M | $-53.55M | $-83.48M | $-68.38M | $-32.23M | $-103.02M | $62.97M | $-80.33M | $-72.24M | $129.09M | $402.71M | $202.13M | $281.59M | $444.09M | $316.89M |
| Net income growth (YoY) | — | -62.0% | -103.6% | -19.9% | +8.8% | +62.9% | -170.9% | -55.9% | +18.1% | +52.9% | -219.6% | +161.1% | -227.6% | +10.1% | +278.7% | +212.0% | -49.8% | +39.3% | +57.7% | -28.6% |
| Profit margin | -1502.6% | -628.9% | -555.2% | -426.9% | -390.8% | -35.2% | -126.5% | -152.3% | -90.8% | -23.9% | -70.2% | 19.9% | -52.9% | -36.9% | 48.2% | 90.8% | 30.6% | 34.0% | 43.7% | 22.7% |